BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1818302)

  • 1. Monoallelic deletions of the P53 gene in Chinese patients with chronic myelogenous leukemia in blastic crisis.
    Chen SJ; Wang Q; Tong JH; Xie WJ; Cao Q; Cai JR; Li XS; Wang ZY; Chen Z; Larsen CJ
    Nouv Rev Fr Hematol (1978); 1991; 33(6):481-4. PubMed ID: 1818302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
    Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
    Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR rearrangements in Ph positive chronic myelocytic leukemia.
    Deng DS; Yang AD; Gong WL; Fei HB; Liu SM
    Chin Med J (Engl); 1991 Aug; 104(8):658-63. PubMed ID: 1680611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Deletion (7)(p11p15): an infrequent abnormality in blast crisis in chronic myeloid leukemia].
    Resino M; Ferro MT; García-Laraña J; García-Sagredo JM; Cabello P; López-Yarto A; San Román C
    Sangre (Barc); 1994 Dec; 39(6):465-7. PubMed ID: 7855700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Southern blot analysis of Bcr, N-ras, H-ras, c-myc and myb proto-oncogenes in blast crisis of chronic myelogenous leukemia.
    Naoe T; Doi S; Yamanaka K; Naito K; Nitta M; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):32-7. PubMed ID: 2741649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [BCR rearrangement and cytogenetic findings in Philadelphia-positive chronic myelocytic leukemia in children].
    Shikano T; Kikuta H; Ishikawa Y; Naito H; Ohkawa M; Nakadate N; Hatae Y; Takeda T
    Rinsho Ketsueki; 1989 Jan; 30(1):29-35. PubMed ID: 2716196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of Ph1-positive leukemia by PCR].
    Hirai H; Ishikawa F
    Rinsho Ketsueki; 1991 Apr; 32(4):319-26. PubMed ID: 2067073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
    Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
    Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the p53 gene in Philadelphia chromosome-positive leukemia including chronic myelogenous leukemia and acute leukemia.
    Tanaka S; Misawa S; Nishigaki H; Ishizaki K; Takashima T; Nakagawa H; Horiike S; Kashima K; Inazawa J; Abe T
    Int J Hematol; 1992 Aug; 56(1):1-7. PubMed ID: 1391801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia.
    Nakayama H; Ishimaru F; Avitahl N; Sezaki N; Fujii N; Nakase K; Ninomiya Y; Harashima A; Minowada J; Tsuchiyama J; Imajoh K; Tsubota T; Fukuda S; Sezaki T; Kojima K; Hara M; Takimoto H; Yorimitsu S; Takahashi I; Miyata A; Taniguchi S; Tokunaga Y; Gondo H; Niho Y; Harada M
    Cancer Res; 1999 Aug; 59(16):3931-4. PubMed ID: 10463586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chromosomal abnormalities in 38 CML cases of various phases].
    Su XY; Cao Q; He KL
    Zhonghua Yi Xue Za Zhi; 1999 Jan; 79(1):34-7. PubMed ID: 11601004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutations of the p53 gene in hematologic neoplasms].
    Mori N; Mizoguchi H
    Nihon Rinsho; 1992 Jun; 50(6):1353-7. PubMed ID: 1518157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.
    Güran S; Bahçe M; Beyan C; Korkmaz K; Yalçin A
    Haematologia (Budap); 1998; 29(3):181-93. PubMed ID: 10069444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary research on the p53 gene rearrangements in the evolution of chronic myelogenous leukemia to blast crisis.
    Chen JC; Liu SM; Fei HB; Gong WL
    J Tongji Med Univ; 1994; 14(4):204-8. PubMed ID: 7760428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.